Back
Speaker illustration

Doctor Alberto Foa'

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Presentations

Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 3

Access
Like
Thumbnail

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

Event: ESC Congress 2018

Topic: Hypertrophic Cardiomyopathy

Session: Atrial fibrillation in hypertrophic cardiomyopathy

Access
Like
Thumbnail

Histopathologic substrates and clinical correlations in type A acute aortic syndromes

Event: ESC Congress 2017

Topic: Aortic Disease

Session: Best Posters in aortic disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources